Baiano, R., Staskon, F., & Miller, R. (2019). Psoriasis patients utilizing secukinumab, ixekizumab, or brodalumab – comparisons to prior biologic medication adherence levels, reasons for switching, and reported changes in disease symptoms. J Drug Assess.
Citação norma ChicagoBaiano, Renee, Francis Staskon, and Rick Miller. "Psoriasis Patients Utilizing Secukinumab, Ixekizumab, or Brodalumab – Comparisons to Prior Biologic Medication Adherence Levels, Reasons for Switching, and Reported Changes in Disease Symptoms." J Drug Assess 2019.
MLA CitationBaiano, Renee, Francis Staskon, and Rick Miller. "Psoriasis Patients Utilizing Secukinumab, Ixekizumab, or Brodalumab – Comparisons to Prior Biologic Medication Adherence Levels, Reasons for Switching, and Reported Changes in Disease Symptoms." J Drug Assess 2019.